New Collaboration to Automate Cell Therapy Manufacturing with Robotics
February 12, 2026
Focus on scaling cell therapy manufacturing using GMP-ready end-to-end robotic biomanufacturing technology
1 min read
False
Advertisement
Technology & Manufacturing
Solving the Problem of Insolubility: Part I
February 11, 2026
As drug discovery unlocks harder, more powerful molecules, solubility has become the bottleneck. The first of a three-part series discusses the roots of the problem
5 min read
Beckman Coulter and Automata in Agentic AI Partnership
February 5, 2026
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
1 min read
Overcoming the Challenges of AI Antibody Analysis
By Ben Holland
February 4, 2026
Cracking the molecular code
5 min read
First 20mL Universal Plunger for Large-Volume On-Body Delivery
February 2, 2026
Plunger for 20mL cartridges aims to meet rising demand for on-body delivery of higher dose therapies
1 min read
Oral GLP-1s Won’t Win on Convenience – They’ll Win on CMC
By Achim Link
January 28, 2026
GLP-1 peptides validated the science. CMC will validate the small molecule modality for GLP-1 efficacy, scalability, and access.
4 min read
Cellares and City of Hope to Automate Manufacturing of Solid Tumor CAR T Cell Therapy
January 27, 2026
Collaboration addresses solid tumor manufacturing bottlenecks and accelerates advancement toward clinical trials
2 min read
Beating Biopharma Manufacturing Bottlenecks with Raman Spectroscopy
By Michelle Sestak
January 26, 2026
A look at the potential of Raman spectroscopy in biopharma – and what else lies on the horizon for this important technique
4 min read
Industry News
Facilities & Equipment
Future of Pharma
Interviews
Business & Trends
Technology & Manufacturing
Sustainability Is the New Survival Strategy
January 21, 2026
Green issues shouldn’t be treated as “woke.” Instead, they should be seen as pharma’s license to operate. Three industry experts discuss.
10 min read
How Speed, Scale, and Science Can Personalize the Pandemic Response
By Andrew Lewis
January 20, 2026
Decades of research have made mRNA a platform for fast, flexible therapeutic innovation, but its promise depends on partnerships.
4 min read
